Epigenomics AG
Epigenomics AG is a molecular diagnostics company developing and manufacturing a pipeline of products for the diagnosis of cancer.
Total raised
€9.8M
€9,770,000
Funding rounds
2
Investors
0
distinct backers
Active since
2013-07
latest 2014-09
Funding by year
EUR raised per yearSignals
Medium confidenceRaise-next likelihood12
base rate 30% for Other
- ▼ Dormant (no round in 3+ cohort gaps)
Exit likelihood13
base rate 12% (2+ rounds)
- ▲ 19y since founding
Timing: dormant vs cohort gap · momentum flat. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2014-10-01 | Other | €4.8M | — | View deal → |
| 2013-08-01 | Other | €5.0M | — | View deal → |
Similar companies
same sector or country- Delivery Hero€7.3BGermany · E-commerce
- Enpal€4.6BGermany · Cleantech
- Auxmoney€3.5BGermany · Fintech
- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Celonis€2.1BGermany · Software